A Study of Mirikizumab (LY3074828) in Pediatric Participants With Crohn's Disease

ClinicalTrials.gov ID: NCT05509777

Public ClinicalTrials.gov record NCT05509777. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced May 8, 2026, 7:56 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3, Multicenter, Randomized Clinical Study to Evaluate Mirikizumab in Pediatric Crohn's Disease

Study identification

NCT ID: NCT05509777
Recruitment status: Recruiting
Study type: Interventional
Phase: Phase 3
Lead sponsor: Eli Lilly and Company; Industry
Enrollment: 90 participants

Conditions and interventions

Conditions

Crohn's Disease

Interventions

Mirikizumab Drug

Drug

Eligibility (public fields only)

Age range: 2 Years to 17 Years
Sex: All
Healthy volunteers: Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: Mar 12, 2024
Primary completion: Nov 30, 2027
Completion: Mar 31, 2028
Last update posted: Mar 26, 2026

2024 – 2028

United States locations

U.S. sites: 15
U.S. states: 12
U.S. cities: 12

Facility	City	State	ZIP	Site status
Cedars Sinai Medical Center	Los Angeles	California	90048	Not yet recruiting
Connecticut Children's Medical Center	Hartford	Connecticut	06032	Recruiting
Emory University	Atlanta	Georgia	30322	Recruiting
Children's Center for Digestive Health Care, LLC	Atlanta	Georgia	30342	Recruiting
Riley Childrens Hospital	Indianapolis	Indiana	46202	Recruiting
Boston Children's Hospital	Boston	Massachusetts	02115	Not yet recruiting
Atlantic Children's Health--Pediatric Gastroenterology	Morristown	New Jersey	07960	Not yet recruiting
Weill Cornell Medical College (WCMC) - Judith Jaffe Multiple Sclerosis Center (JJMSC)	New York	New York	10021-5663	Recruiting
Icahn School of Medicine at Mount Sinai	New York	New York	10029	Recruiting
Columbia University Medical Center/New York Presbyterian	New York	New York	10032	Recruiting
Childrens Medical Center	Dayton	Ohio	45404	Recruiting
Children's Hospital of Philadelphia	Philadelphia	Pennsylvania	19146	Recruiting
Cook Children's Medical Center	Fort Worth	Texas	76104	Recruiting
University of Vermont Medical Center	Burlington	Vermont	05401	Recruiting
Seattle Children's Hospital	Seattle	Washington	98105	Not yet recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 66 non-U.S. sites.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT05509777, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted Mar 26, 2026 · Synced May 8, 2026

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT05509777 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →